4//SEC Filing
Pillar Pharmaceuticals III, L.P. 4
Accession 0000899243-18-001531
CIK 0000861838other
Filed
Jan 18, 7:00 PM ET
Accepted
Jan 19, 4:51 PM ET
Size
7.8 KB
Accession
0000899243-18-001531
Insider Transaction Report
Form 4
Pillar Invest Corp
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-17$2.40/sh−200,000$480,000→ 0 total(indirect: See Footnote)
Pillar Pharmaceuticals III, L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2018-01-17$2.40/sh−200,000$480,000→ 0 total(indirect: See Footnote)
Footnotes (2)
- [F1]The shares sold on this date were sold in multiple transactions. This price is the weighted average sales price per share of all shares sold on this date; the actual sale prices per share range from $2.40-$2.405. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
- [F2]Shares sold by Pillar Pharmaceuticals III, L.P. ("Pillar III"), of which Pillar Invest Corporation ("Pillar GP") is the general partner. Pillar GP disclaims Section 16 beneficial ownership of the securities beneficially owned by Pillar III and this report shall not be deemed an admission that Pillar GP is the Section 16 beneficial owner of any such securities, except to the extent of its pecuniary interest therein, if any, by virtue of its ownership interest in Pillar III. As of the date hereof, Pillar III owns directly 2,871,839 shares of common stock of the Issuer.
Documents
Issuer
IDERA PHARMACEUTICALS, INC.
CIK 0000861838
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001576891
Filing Metadata
- Form type
- 4
- Filed
- Jan 18, 7:00 PM ET
- Accepted
- Jan 19, 4:51 PM ET
- Size
- 7.8 KB